comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 11:47:20 - browse：55

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Virginia high school admissions case could be legal follow
Next article： Is mRNA technology the right fit for flu shots? Experts aren’t so sure

explore

WSS

UnitedHealth, in a surprise, takes aim at Steward’s physician group

J&J to emphasize cancer drugs, stop much of its vaccine research

Covid silver lining: Unprecedented look at human immune system

Drug companies' payments and gifts affect physicians' prescribing

Medicare Advantage 2025 payments will dip, Biden administration says

Alzheimer's risk factor APOE4 may be a distinct form of the disease

hotspot

comprehensive

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Wikipedia

How one medical school became remarkably diverse

Medicare Advantage 2025 payments will dip, Biden administration says

After affirmative action ruling, medical educators look to 'holistic review'

What don’t we know about an Alzheimer’s drug side effect?

Activists slam private health insurers over coverage restrictions

The EPA's new lead rule: How one expert crunched the numbers

Moonlake's readout produced a cash windfall. Risks remain

People with mental disorders often marry others with same

Dobbs anniversary: the lost opportunity of abortion as health care

Young boy dies in trial for Pfizer Duchenne gene therapy

hotspot

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Republican states more likely to report Covid vaccine side effects

Takeda, Janssen join wearable maker to measure scratching

Rep. Raul Ruiz on the physician shortage and more

Pancreatic cancer is often deadly, but new discoveries are raising hope

Multiple sclerosis has subtypes with different best treatments: study

knowledge

explore

explore

Wikipedia